Back to Search
Start Over
Breath Therapeutics begins phase 3 BOSTON clinical studies of L- CsA- i to treat bronchiolitis obliterans syndrome
- Source :
- PharmaBiz. March 27, 2019
- Publication Year :
- 2019
-
Abstract
- Breath Therapeutics, a private company developing advanced inhaled therapeutics in severe pulmonary orphan diseases, announced the initiation of the phase 3 BOSTON clinical studies of L- CsA- i for the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.580246774